The IRS relies extensively on IT systems to collect more than $3 trillion in taxes and distribute over $400 billion in refunds annually. In FY 2020, the IRS expects to spend approximately $3.2 billion ...

Inefficient tools, unhappy staff members, a shortage of workers, compliance concerns and soaring costs. Those workforce and operational challenges are a recipe for operational disarray for the ...

Research and conversations have shown that the disparate nature of operations across multiple clouds creates significant challenges for organizations. Securing and deploying apps, data portability, ...

Solesence may be facing mounting financial challenges, margin compression, and slowing revenue growth, prompting a Strong Sell rating with a $0.55/share target. SLSN's operational headwinds include ...

PayPal is a leading online payment platform with a strong business presence. The company faces competition from other payment providers in the market. The article provides an overview of PayPal's ...

Mumbai, Dec 4: In light of significant flight disruptions, IndiGo's CEO Pieter Elbers acknowledged on Thursday that the airline has not met its service expectations. He emphasized that the immediate ...

Major Drilling ((TSE:MDI)) has held its Q2 earnings call. Read on for the main highlights of the call. The recent earnings call for Major Drilling presented a mixed sentiment, with the company ...

Recent government legislation and initiatives have prompted positive momentum in the energy industry. From regulatory matters to technology upgrades to renewable energy trends boosted by the Inflation ...

The uptick in U.S. medical utilization provides a favorable backdrop for medical device firms as the rest of 2023 unfolds. However, we think Smith & Nephew SN. may not be able to fully capitalize on ...

The Coast Guard Cutter Polar Star (WAGB-10) is in the fast Ice Jan. 2, 2020, approximately 20 miles north of McMurdo Station, Antarctica. The 399-foot icebreaker is the only ship in U.S. service ...

We describe our experience running the investigator-initiated phase III randomized, fully accrued, Aspirin for Dukes C and high-risk Dukes B Colorectal cancer trial (ASCOLT, ClinicalTrials.gov ...